CardioGenics Holdings Inc (CGNH)
USD 0.0
(9900.0%)
USD 0.0
(9900.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2015 | - USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | -100.0% |
| 2012 | 1297.00 USD | -85.39% |
| 2011 | 8876.00 USD | 0.0% |
| 2010 | - USD | 100.0% |
| 2009 | -115.4 Thousand USD | -179.15% |
| 2008 | 145.8 Thousand USD | 11.95% |
| 2007 | 130.23 Thousand USD | 60.58% |
| 2006 | 81.1 Thousand USD | -7.07% |
| 2005 | 87.28 Thousand USD | 561.68% |
| 2004 | -18.9 Thousand USD | 93.92% |
| 2003 | -311.14 Thousand USD | 40.36% |
| 2002 | -521.67 Thousand USD | 91.59% |
| 2001 | -6.2 Million USD | 12.51% |
| 2000 | -7.09 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2016 Q1 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 FY | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 FY | - USD | -100.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | -100.0% |
| 2012 Q1 | 1136.00 USD | -54.12% |
| 2012 Q4 | 161.00 USD | 0.0% |
| 2012 FY | 1297.00 USD | -85.39% |
| 2012 Q3 | - USD | 0.0% |
| 2012 Q2 | - USD | -100.0% |
| 2011 FY | 8876.00 USD | 0.0% |
| 2011 Q1 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q4 | 2476.00 USD | -61.31% |
| 2011 Q3 | 6400.00 USD | 0.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 FY | - USD | 100.0% |
| 2010 Q2 | - USD | 0.0% |
| 2010 Q1 | - USD | 100.0% |
| 2010 Q4 | - USD | 0.0% |
| 2009 Q1 | 31.05 Thousand USD | 19.17% |
| 2009 FY | -115.4 Thousand USD | -179.15% |
| 2009 Q4 | -115.4 Thousand USD | 0.0% |
| 2009 Q2 | 29.95 Thousand USD | -3.56% |
| 2009 Q3 | - USD | -100.0% |
| 2008 Q3 | 44.64 Thousand USD | 46.09% |
| 2008 Q1 | 38.49 Thousand USD | 19.89% |
| 2008 FY | 145.8 Thousand USD | 11.95% |
| 2008 Q4 | 26.06 Thousand USD | -41.62% |
| 2008 Q2 | 30.55 Thousand USD | -20.63% |
| 2007 FY | 130.23 Thousand USD | 60.58% |
| 2007 Q4 | 32.11 Thousand USD | 20.79% |
| 2007 Q3 | 26.58 Thousand USD | -40.46% |
| 2007 Q2 | 44.64 Thousand USD | 10.73% |
| 2007 Q1 | 40.32 Thousand USD | 115.86% |
| 2006 Q4 | 18.68 Thousand USD | 394.93% |
| 2006 Q3 | -6334.00 USD | -113.65% |
| 2006 Q2 | 46.41 Thousand USD | 72.68% |
| 2006 Q1 | 26.87 Thousand USD | 89.95% |
| 2006 FY | 81.1 Thousand USD | -7.07% |
| 2005 Q1 | 4031.00 USD | -88.07% |
| 2005 FY | 87.28 Thousand USD | 561.68% |
| 2005 Q4 | 14.15 Thousand USD | -54.74% |
| 2005 Q3 | 31.26 Thousand USD | 71.73% |
| 2005 Q2 | 18.2 Thousand USD | 351.6% |
| 2004 Q2 | -4560.00 USD | -122.46% |
| 2004 FY | -18.9 Thousand USD | 93.92% |
| 2004 Q4 | 33.78 Thousand USD | 675.04% |
| 2004 Q1 | 20.3 Thousand USD | 158.48% |
| 2004 Q3 | 4359.00 USD | 195.59% |
| 2003 Q1 | -113.93 Thousand USD | -55.57% |
| 2003 Q4 | -34.71 Thousand USD | -39.59% |
| 2003 FY | -311.14 Thousand USD | 40.36% |
| 2003 Q3 | -24.87 Thousand USD | 74.91% |
| 2003 Q2 | -99.11 Thousand USD | 13.01% |
| 2002 Q3 | -168.31 Thousand USD | -88.81% |
| 2002 Q2 | -89.14 Thousand USD | 66.99% |
| 2002 Q1 | -270.07 Thousand USD | -4705.66% |
| 2002 FY | -521.67 Thousand USD | 91.59% |
| 2002 Q4 | -73.23 Thousand USD | 56.49% |
| 2001 FY | -6.2 Million USD | 12.51% |
| 2001 Q3 | 12.4 Thousand USD | 111.68% |
| 2001 Q2 | -106.22 Thousand USD | 97.59% |
| 2001 Q1 | -4.41 Million USD | -159.69% |
| 2001 Q4 | 5864.00 USD | -52.73% |
| 2000 Q1 | -1.39 Million USD | 0.0% |
| 2000 FY | -7.09 Million USD | 0.0% |
| 2000 Q4 | -1.69 Million USD | 47.23% |
| 2000 Q2 | -1.43 Million USD | -2.61% |
| 2000 Q3 | -3.21 Million USD | -124.96% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Bio Medica Corporation | -193 Thousand USD | 100.0% |
| Arrayit Corporation | 2.57 Million USD | 100.0% |
| Atlantic International Corp. | -154.23 Thousand USD | 100.0% |
| Biocept, Inc. | -2.58 Million USD | 100.0% |
| Bioqual, Inc. | 7.42 Million USD | 100.0% |
| DermTech, Inc. | 276 Thousand USD | 100.0% |
| Global WholeHealth Partners Corporation | - USD | NaN% |
| Hangzhou Tigermed Consulting Co., Ltd. | 6.73 Billion USD | 100.0% |
| HTG Molecular Diagnostics, Inc. | 1.79 Million USD | 100.0% |
| iMD Companies, Inc. | -23.63 Thousand USD | 100.0% |
| IDenta Corp. | 662.97 Thousand USD | 100.0% |
| Interpace Biosciences, Inc. | 23.04 Million USD | 100.0% |
| Integrative Health Technologies, Inc. | 77.57 Thousand USD | 100.0% |
| InVitro International | 635.98 Thousand USD | 100.0% |
| Lumos Diagnostics Holdings Limited | 6.56 Million USD | 100.0% |
| Many Bright Ideas Technologies Inc. | - USD | NaN% |
| Medical Imaging Corp. | 1.09 Million USD | 100.0% |
| NovelStem International Corp. | 12 Thousand USD | 100.0% |
| Optigenex Inc. | -102.96 Thousand USD | 100.0% |
| PharmChem, Inc. | 3.9 Million USD | 100.0% |
| Proteome Sciences plc | 2.09 Million USD | 100.0% |
| Response Genetics, Inc | 3.94 Million USD | 100.0% |
| Rennova Health, Inc. | 6.26 Million USD | 100.0% |
| RushNet, Inc. | 1.1 Million USD | 100.0% |
| ScreenPro Security Inc. | 856.57 Thousand USD | 100.0% |
| Stella Diagnostics Inc. | - USD | NaN% |
| StageZero Life Sciences Ltd. | -403.74 Thousand USD | 100.0% |
| Todos Medical Ltd. | 4.31 Million USD | 100.0% |